furocoumarin < further < furthered

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by further

Number of relevant bibliographic references: 582.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000002 (2020)	Jing Xu [République populaire de Chine] ; Han Zhang [République populaire de Chine] ; Jinfang Zheng [États-Unis] ; Philippe Dovoedo [États-Unis] ; Yanbin Yin [États-Unis]	eCAMI: simultaneous classification and motif identification for enzyme annotation.
000008 (2020)	H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine]	[Potential antiviral therapeutics for 2019 Novel Coronavirus].
000031 (2020)	Valery V. Panyukov ; Sergey S. Kiselev [Russie] ; Olga N. Ozoline [Russie]	Unique k-mers as Strain-Specific Barcodes for Phylogenetic Analysis and Natural Microbiome Profiling
000043 (2020)	Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan]	The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
000060 (2020)	Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine]	The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.
000074 (2020)	Muhammad Tahir Ul Qamar [République populaire de Chine] ; Safar M. Alqahtani [Arabie saoudite] ; Mubarak A. Alamri [Arabie saoudite] ; Ling-Ling Chen [République populaire de Chine]	Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants†
000111 (2020)	David A. Schwartz [États-Unis] ; Ashley L. Graham	Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000118 (2020)	Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]	Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000121 (2020)	Jieliang Chen	Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses
000138 (2020)	Chek Meng Poh [République populaire de Chine] ; Jian Zheng [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Zi Wei Chang [Singapour] ; Thi H. O. Nguyen [Australie] ; Laurent Rénia [Singapour] ; Katherine Kedzierska [Australie] ; Stanley Perlman [États-Unis] ; Leo L. M. Poon [République populaire de Chine]	Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes
000142 (2020)	Yuan Yuan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Ruchao Peng [République populaire de Chine] ; Chunrui Li [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Qihui Wang [République populaire de Chine] ; George Fu Gao [République populaire de Chine]	Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species.
000148 (2020)	Ju Kim [Corée du Sud] ; Ye Lin Yang ; Yongsu Jeong [Corée du Sud] ; Yong-Suk Jang [Corée du Sud]	Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis.
000151 (2020)	Marie E. Killerby ; Holly M. Biggs ; Claire M. Midgley ; Susan I. Gerber ; John T. Watson	Middle East Respiratory Syndrome Coronavirus Transmission
000154 (2020)	Alice N. Kiyong'A [Kenya] ; Elizabeth A J. Cook [Kenya] ; Nisreen M A. Okba [Pays-Bas] ; Velma Kivali [Kenya] ; Chantal Reusken [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] ; Eric M. Fèvre [Kenya]	Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Seropositive Camel Handlers in Kenya.
000159 (2020)	Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde]	Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
000160 (2020)	Ling Xu [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mengji Lu [République populaire de Chine] ; Dongliang Yang [République populaire de Chine] ; Xin Zheng [République populaire de Chine]	Liver injury during highly pathogenic human coronavirus infections.
000167 (2020)	Hossam M. Ashour [États-Unis] ; Walid F. Elkhatib [Égypte] ; Md Masudur Rahman [Bangladesh] ; Hatem A. Elshabrawy [États-Unis]	Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.
000212 (2020)	Hayne Cho Park ; Sang-Ho Lee ; Juhee Kim ; Do Hyoung Kim ; Ajin Cho ; Hee Jung Jeon ; Jieun Oh ; Jung-Woo Noh ; Da-Wun Jeong ; Yang-Gyun Kim ; Chang-Hee Lee ; Kyung Don Yoo [Corée du Sud] ; Young-Ki Lee	Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study.
000213 (2020)	Jin-Won Noh [Pays-Bas] ; Ki-Bong Yoo ; Young Dae Kwon ; Jin Hyuk Hong ; Yejin Lee ; Kisoo Park [Corée du Sud]	Effect of Information Disclosure Policy on Control of Infectious Disease: MERS-CoV Outbreak in South Korea
000247 (2020)	Barbara Holstein	Coronavirus 101
000250 (2020)	Zhixin Liu [République populaire de Chine] ; Xiao Xiao [République populaire de Chine] ; Xiuli Wei [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Jing Yang [République populaire de Chine] ; Huabing Tan [République populaire de Chine] ; Jianyong Zhu [République populaire de Chine] ; Qiwei Zhang [République populaire de Chine] ; Jianguo Wu [République populaire de Chine] ; Long Liu [République populaire de Chine]	Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "further" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "further" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    further
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021